AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,370,517 | -3.6% | 2,419,425 | +24.7% | 2.91% | +11.1% |
| Q2 2023 | $90,610,116 | +352.4% | 1,940,675 | +270.7% | 2.62% | +343.8% |
| Q1 2023 | $20,030,067 | +4.3% | 523,525 | +49.4% | 0.59% | +9.6% |
| Q4 2022 | $19,208,770 | +31.2% | 350,525 | -18.5% | 0.54% | +26.8% |
| Q3 2022 | $14,642,000 | +2069.2% | 430,000 | +1860.1% | 0.42% | +4150.0% |
| Q3 2020 | $675,000 | – | 21,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 4,907,829 | $103,801,000 | 22.97% |
| venBio Partners LLC | 2,171,664 | $45,931,000 | 8.28% |
| Versant Venture Management, LLC | 617,727 | $13,065,000 | 6.99% |
| Atlas Venture Life Science Advisors, LLC | 2,232,251 | $47,212,000 | 4.34% |
| Yiheng Capital Management, L.P. | 1,551,090 | $32,806,000 | 1.67% |
| Redmile Group, LLC | 1,602,285 | $33,888,000 | 0.77% |
| Boxer Capital, LLC | 831,495 | $17,586,000 | 0.68% |
| Cormorant Asset Management, LP | 403,787 | $8,540,000 | 0.51% |
| Integral Health Asset Management, LLC | 85,000 | $1,798,000 | 0.50% |
| HHLR ADVISORS, LTD. | 1,359,152 | $28,746,000 | 0.44% |